S. Senju

发表

Evidence that HLA class II‐restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

H. Saya, H. Fujita, S. Senju, 1998, European journal of immunology.

Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration

Huihao Zhou, Jeffrey H. Chuang, Ivan Dotu, 2014, Science.

Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro

S. Senju, Y. Nishimura, H. Hamana, 2018, Oncoimmunology.

Identification of SARS-COV Spike Protein-Derived and HLA-A2-Restricted Human CTL Epitopes by Using a New Muramyl Dipeptide-Derivative Adjuvant

M. Kohara, S. Senju, Y. Nishimura, 2010, International journal of immunopathology and pharmacology.

Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses

S. Senju, Y. Nishimura, T. Kageshita, 2004, Clinical Cancer Research.

Essential role for ZAP-70 in both positive and negative selection of thymocytes

K. Nakayama, K. Nakayama, D. Loh, 1995, Nature.

Augmentation of immune response by altered peptide ligands of the antigenic peptide in a human CD4+ T-cell clone reacting to TEL/AML1 fusion protein.

H. Fujita, S. Senju, S. Matsushita, 1999, Tissue antigens.

Peptides derived from human insulin‐like growth factor‐II mRNA binding protein 3 can induce human leukocyte antigen‐A2‐restricted cytotoxic T lymphocytes reactive to cancer cells

S. Senju, Y. Nishimura, K. Shiraishi, 2011, Cancer science.

Systematic Analysis of the Combinatorial Nature of Epitopes Recognized by TCR Leads to Identification of Mimicry Epitopes for Glutamic Acid Decarboxylase 65-Specific TCRs1

S. Senju, Y. Nishimura, Hirotake Tsukamoto, 2003, The Journal of Immunology.

TCRs Glutamic Acid Decarboxylase 65-Specific to Identification of Mimicry Epitopes for LeadsNature of Epitopes Recognized by TCR Systematic Analysis of the Combinatorial

S. Senju, Hirotake Tsukamoto, K. Maenaka, 2002 .

Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells

S. Senju, Y. Nishimura, Takaaki Ito, 2014, PloS one.

Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population

J. Kira, H. Mitsuya, H. Hashimoto, 2001, Modern rheumatology.

Cytokine-Dependent Modification of IL-12p70 and IL-23 Balance in Dendritic Cells by Ligand Activation of Vα24 Invariant NKT Cells1

S. Senju, O. Ishihara, Motoharu Suzuki, 2009, The Journal of Immunology.

Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response

T. Naoe, Y. Mizoro, S. Senju, 2018, Stem cell reports.

Allele-specific expression of the cytoplasmic exon of HLA-DQB1 gene

T. Sasazuki, S. Senju, Y. Nishimura, 1992, Immunogenetics.

Humoral immune response directed against LEDGF in patients with VKH.

S. Senju, Y. Nishimura, S. Ohno, 2001, Immunology letters.

Activation of Antigen-Specific Cytotoxic T Lymphocytes by β2-Microglobulin or TAP1 Gene Disruption and the Introduction of Recipient-Matched MHC Class I Gene in Allogeneic Embryonic Stem Cell-Derived Dendritic Cells1

S. Senju, Y. Nishimura, S. Fukushima, 2008, The Journal of Immunology.

Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology

S. Senju, Y. Nishimura, Y. Tomita, 2016, PloS one.

Cancer therapy with major histocompatibility complex‐deficient and interferon β‐producing myeloid cells derived from allogeneic embryonic stem cells

S. Senju, Y. Nishimura, M. Takeya, 2019, Cancer science.

Therapy of primary and metastatic liver cancer by human iPS cell‐derived myeloid cells producing interferon‐β

S. Senju, Y. Nishimura, M. Takeya, 2017, Journal of hepato-biliary-pancreatic sciences.

Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3.

S. Senju, T. Seki, K. Fukuda, 2019, Biochemical and biophysical research communications.

Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.

S. Senju, Y. Nishimura, S. Fukushima, 2018, Cancer research.

IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age

S. Senju, Y. Nishimura, S. Swain, 2015, Nature Communications.

DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4+ T cells and CD8+ T cells

S. Senju, M. Ogawa, Y. Nishimura, 2005, Cancer science.

[Cancer immunotherapy by utilizing dedritic cells derived from pluripotent stem cells].

S. Senju, Y. Nishimura, S. Fukushima, 2011, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Heat shock protein 105 is overexpressed in a variety of human tumors.

S. Senju, M. Ogawa, Y. Nishimura, 2003, Oncology reports.

Identification of the H2‐Kd‐restricted cytotoxic T lymphocyte epitopes of a tumor‐associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice

S. Senju, Y. Nishimura, H. Baba, 2009, Cancer science.

Identification of human and mouse GP-1, a putative member of a novel G-protein family.

S. Senju, Y. Nishimura, 1997, Biochemical and biophysical research communications.

Novel Antibody for the Treatment of Transthyretin Amyloidosis*

S. Senju, H. Jono, Y. Ando, 2016, The Journal of Biological Chemistry.

Identification of SPARC as a candidate target antigen for immunotherapy of various cancers

Yusuke Nakamura, Y. Furukawa, S. Senju, 2010, International journal of cancer.

Identification and immunocytochemical analysis of DCNP1, a dendritic cell-associated nuclear protein.

K. Matsushima, E. Yumoto, S. Senju, 2002, Biochemical and biophysical research communications.

Immune‐suppressive effects of interleukin‐6 on T‐cell‐mediated anti‐tumor immunity

S. Senju, Y. Nishimura, H. Oshiumi, 2017, Cancer science.

Bisphenol A in combination with TNF-α selectively induces Th2 cell-promoting dendritic cells in vitro with an estrogen-like activity

S. Senju, O. Ishihara, Motoharu Suzuki, 2010, Cellular and Molecular Immunology.

Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression

S. Senju, Y. Nishimura, Hirotake Tsukamoto, 2013, Cancer Immunology Research.

An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.

S. Senju, Y. Nishimura, H. Baba, 2009, Immunology letters.

Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.

S. Senju, Y. Nishimura, Hirotake Tsukamoto, 2017, Cancer research.

Functional significance of the Fas molecule in naive lymphocytes.

D. Loh, K. Nakayama, S. Senju, 1996, International immunology.

Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL1

S. Senju, Y. Nishimura, Y. Uemura, 2007, The Journal of Immunology.

Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand1

S. Senju, Y. Nishimura, Y. Uemura, 2005, The Journal of Immunology.

Generation of a large number of functional dendritic cells from human monocytes expanded by forced expression of cMYC plus BMI1.

S. Senju, Y. Nishimura, Y. Tomita, 2013, Human immunology.

Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells

S. Senju, Y. Nishimura, S. Fukushima, 2009, Journal of immunotherapy.

Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.

S. Senju, S. Matsushita, Y. Nishimura, 1997, Human immunology.

Immunocytochemical Analyses and Targeted Gene Disruption of GTPBP1

S. Aizawa, S. Senju, Y. Nishimura, 2000, Molecular and Cellular Biology.

BCR–ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells

T. Naoe, S. Senju, S. Okada, 2016, Cellular & Molecular Immunology.

Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.

S. Senju, Y. Nishimura, T. Makino, 2020, Pigment cell & melanoma research.

A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells.

S. Senju, Y. Nishimura, T. Yoshimoto, 2022, ALTEX.

Immunotherapy with 4-1BBL-Expressing iPS Cell‐Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma

S. Senju, S. Fukushima, H. Ihn, 2021, International journal of molecular sciences.

Application of iPS cell-derived macrophages to cancer therapy

S. Senju, Y. Nishimura, M. Haruta, 2014, Oncoimmunology.

B‐Raf‐mediated signaling pathway regulates T cell development

S. Senju, Y. Nishimura, L. Wojnowski, 2008, European journal of immunology.

A novel tumor‐associated antigen, cell division cycle 45‐like can induce cytotoxic T‐lymphocytes reactive to tumor cells

Yusuke Nakamura, S. Senju, Y. Nishimura, 2011, Cancer science.

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

S. Senju, Y. Nishimura, H. Baba, 2006, Cancer research.

Melanoma , B 16-F 10 Protective Immunity against Highly Metastatic Mouse Glypican-3 , a Recently Identified Oncofetal Antigen , Induce Derived Dendritic Cells Expressing − Embryonic Stem Cell

S. Senju, Y. Nishimura, H. Baba, 2006 .

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Nakamura, S. Senju, Y. Nishimura, 2013, Clinical Cancer Research.

Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination1

S. Senju, Y. Nishimura, Y. Uemura, 2004, The Journal of Immunology.

Antitumor Vaccination with Antigenic Protein: Application to Dendritic Cells Expressing Chemokine Along In Vivo by Embryonic Stem Cell-Derived Enhanced Priming of Antigen-Specific CTLs

S. Senju, Y. Uemura, S. Hirata, 2003 .

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Yusuke Nakamura, Y. Furukawa, T. Katagiri, 2004, Clinical Cancer Research.

Gene cloning of immunogenic antigens overexpressed in pancreatic cancer.

S. Senju, M. Ogawa, Y. Nishimura, 2001, Biochemical and biophysical research communications.

The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.

S. Senju, S. Matsushita, Y. Nishimura, 1998, Human immunology.

Pluripotent stem cell-derived dendritic cells for immunotherapy.

S. Senju, Y. Nishimura, S. Fukushima, 2010, Frontiers in bioscience.

Genetically Manipulated Human Embryonic Stem Cell‐Derived Dendritic Cells with Immune Regulatory Function

Yusuke Nakamura, T. Katagiri, S. Senju, 2007, Stem cells.

Cancer prevention with semi-allogeneic ES cell-derived dendritic cells.

S. Senju, Y. Nishimura, M. Shinohara, 2005, Biochemical and biophysical research communications.

Death-1 Ligand Peptide along with TRAIL or Programmed Myelin Oligodendrocyte Glycoprotein Stem Cell-Derived Dendritic Cells Expressing Encephalomyelitis by Transfer of Embryonic Prevention of Experimental Autoimmune

S. Senju, Y. Nishimura, Y. Uemura, 2005 .

Autoimmunity against neurofilament protein and its possible association with HLA-DRB1*1502 allele in glaucoma.

J. Kira, S. Senju, Y. Nishimura, 2005, Immunology letters.

Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells.

K. Yamamura, S. Senju, Y. Nishimura, 2003, Blood.

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin

S. Senju, Y. Ando, M. Ueda, 2017, Scientific Reports.

Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4+ T Cell Epitopes of Tumor-Associated Antigens

S. Senju, Y. Nishimura, H. Sugiyama, 2013, PloS one.

Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells

S. Tsuzuki, S. Senju, Y. Nishimura, 2015, Cancer Immunology Research.

Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner.

S. Senju, Y. Nishimura, T. Azuma, 2005, Blood.

Identification of CDCA1‐derived long peptides bearing both CD4+ and CD8+ T‐cell epitopes: CDCA1‐specific CD4+ T‐cell immunity in cancer patients

Yusuke Nakamura, S. Senju, Y. Nishimura, 2014, International journal of cancer.

An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

S. Senju, Y. Nishimura, K. Kono, 2016, Oncoimmunology.

Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response

S. Senju, Y. Nishimura, K. Kono, 2015, Oncoimmunology.

Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

S. Senju, Y. Nishimura, S. Fukushima, 2011, Gene Therapy.

Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells

Yusuke Matsunaga, Shinya Yamanaka, Yasuharu Nishimura, 2009, Stem cells.

The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapy

Yusuke Nakamura, S. Senju, Y. Nishimura, 2009, International journal of cancer.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.

I. Endo, T. Kaisho, S. Senju, 2019, Cell reports.

Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2.

S. Senju, Y. Nishimura, Y. Ando, 2014, Stem cell research.

Induced pluripotent stem cell-derived, genetically engineered myeloid cells as unlimited cell source for dendritic cell-related cancer immunotherapy

I. Endo, H. Ohdan, S. Senju, 2021 .

Specificity, degeneracy, and molecular mimicry in antigen recognition by HLA-Class II restricted T cell receptors: implications for clinical medicine

S. Senju, Y. Nishimura, K. Maenaka, 2003, Modern rheumatology.

Regression of intestinal adenomas by vaccination with heat shock protein 105‐pulsed bone marrow‐derived dendritic cells in ApcMin/+ mice

J. Kira, S. Senju, Y. Nishimura, 2007, Cancer science.

Therapeutic Effect of Human iPS-Cell–Derived Myeloid Cells Expressing IFN-β against Peritoneally Disseminated Cancer in Xenograft Models

S. Senju, Y. Nishimura, M. Haruta, 2013, PloS one.

[Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].

S. Senju, Y. Nishimura, T. Nakatsura, 2008, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

al. et, K. Nakayama, S. Senju, 1995, Science.

Immunotherapy with pluripotent stem cell-derived dendritic cells

S. Senju, Y. Nishimura, S. Fukushima, 2011, Seminars in Immunopathology.

Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells

S. Senju, Y. Nishimura, Takaaki Ito, 2010, The Journal of Immunology.

Therapeutic effect of α‐galactosylceramide‐loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells

S. Senju, Y. Nishimura, T. Nakatsura, 2005, Cancer science.

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response

Y. Hagiya, H. Ohdan, S. Senju, 2020, Oncoimmunology.

iPS cell serves as a source of dendritic cells for in vitro dengue virus infection model.

K. Morita, S. Senju, Y. Nishimura, 2018, The Journal of general virology.

Mouse and human GTPBP2, newly identified members of the GP-1 family of GTPase.

S. Senju, Y. Nishimura, H. Kudo, 2000, Biochemical and biophysical research communications.

Pluripotent stem cells as source of dendritic cells for immune therapy

S. Senju, Y. Nishimura, S. Fukushima, 2010, International journal of hematology.

Establishment of an expression cloning system for CD4+ T cell epitopes.

S. Senju, Y. Nishimura, Y. Uemura, 2001, Biochemical and biophysical research communications.

Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.

I. Hisatome, S. Senju, Y. Nishimura, 2004, Biochemical and biophysical research communications.

Therapy of Peritoneally Disseminated Colon Cancer by TAP-Deficient Embryonic Stem Cell–Derived Macrophages in Allogeneic Recipients

S. Senju, Y. Nishimura, M. Haruta, 2014, The Journal of Immunology.

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

K. Wakamatsu, S. Ito, S. Senju, 2004, Clinical Cancer Research.

TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells

S. Senju, Y. Nishimura, Y. Tomita, 2012, Gene Therapy.

Modulation of exosome‐mediated mRNA turnover by interaction of GTP‐binding protein 1 (GTPBP1) with its target mRNAs

S. Senju, Y. Nishimura, S. Chung, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Identification of a novel autoantigen UACA in patients with panuveitis.

S. Senju, Y. Nishimura, Y. Nishimura, 2001, Biochemical and biophysical research communications.

Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons

S. Senju, Y. Nishimura, M. Jinnin, 2015, Cancer Immunology Research.

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Yusuke Nakamura, Hidewaki Nakagawa, Hideo Baba, 2008, Clinical Cancer Research.

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

S. Senju, Y. Nishimura, H. Baba, 2006, Clinical Cancer Research.

Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice

Yusuke Nakamura, Y. Furukawa, T. Katagiri, 2004, Clinical Cancer Research.

Identification of a NovelTumor-Associated Antigen , Cadherin 3 / P-Cadherin , as a PossibleTarget for Immunotherapy of Pancreatic , Gastric , and Colorectal Cancers

Yusuke Nakamura, H. Nakagawa, S. Senju, 2008 .

Head and neck cancer antigens recognized by the humoral immune system.

Yasuharu Nishimura, Akira Inokuchi, Motohiro Sawatsubashi, 2002, Biochemical and biophysical research communications.

Identification of immunogenic LY6K long peptide encompassing both CD4+ and CD8+ T-cell epitopes and eliciting CD4+ T-cell immunity in patients with malignant disease

Yusuke Nakamura, S. Senju, Y. Nishimura, 2014, Oncoimmunology.

Development of an Ideal and Potent Cancer Immunotherapy Designed by Consideration of HLA Polymorphism

S. Senju, Y. Nishimura, Y. Tomita, 2013 .

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Yusuke Nakamura, Y. Furukawa, T. Katagiri, 2003, Biochemical and biophysical research communications.

HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTL

Yusuke Nakamura, S. Senju, Y. Nishimura, 2008, International journal of cancer.

Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin‐like protein, originally defined by the SEREX method

S. Senju, Y. Nishimura, Masaaki Ito, 2002, European journal of immunology.

Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation.

S. Senju, Y. Nishimura, M. Yanai, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer

Y. Nakamura, H. Nakagawa, S. Senju, 2010, British Journal of Cancer.

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin

S. Senju, Y. Ando, M. Ueda, 2017, Scientific Reports.

Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment

S. Senju, Takaaki Ito, Y. Ando, 2016, PloS one.

Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta

S. Senju, Y. Nishimura, H. Katabuchi, 2018, Cancer science.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.

I. Endo, T. Kaisho, S. Senju, 2019, Cell reports.

Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer’s Disease via Angiotensin AT1 Receptor

S. Senju, Yu Hasegawa, N. Nakagata, 2017, American journal of hypertension.

Dengue virus susceptibility in novel immortalized myeloid cells

S. Senju, J. Shimizu, A. Yamanaka, 2020, Heliyon.

Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.

S. Senju, Yu Hasegawa, N. Nakagata, 2016, Journal of Alzheimer's disease : JAD.

lymphocytes in an HLA class II-restricted manner Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T

S. Senju, Y. Nishimura, T. Azuma, 2013 .

Direct recognition and lysis of leukemia cells by WT1-speciﬁc CD4 (cid:1) T lymphocytes in an HLA class II–restricted manner

S. Senju, Y. Nishimura, T. Azuma, 2005 .

Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha.

S. Senju, S. Fukushima, H. Ihn, 2021, Journal of dermatological science.